During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 2.18 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $0.30, reflecting an intraday loss of -3.29% or -$0.01. The 52-week high for the GLM